D
Dawn K. Smith
Researcher at Centers for Disease Control and Prevention
Publications - 130
Citations - 11227
Dawn K. Smith is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Pre-exposure prophylaxis & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 45, co-authored 130 publications receiving 9936 citations. Previous affiliations of Dawn K. Smith include Brown University.
Papers
More filters
Journal ArticleDOI
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Michael C. Thigpen,Poloko Kebaabetswe,Lynn A. Paxton,Dawn K. Smith,Charles E. Rose,Tebogo M. Segolodi,Faith L. Henderson,Sonal R Pathak,Fatma A. Soud,Kata Chillag,Rodreck Mutanhaurwa,Lovemore Ian Chirwa,Michael Kasonde,Daniel Abebe,Evans Buliva,Roman Gvetadze,Sandra H. Johnson,Thom Sukalac,Vasavi Thomas,Clyde E. Hart,Jeffrey A. Johnson,C. Kevin Malotte,Craig W. Hendrix,John T. Brooks +23 more
TL;DR: Daily TDF-FTC prophylaxis prevented HIV infection in sexually active heterosexual adults and had a significant decline in bone mineral density, which remains unknown.
Monitoring selected national HIV prevention and care objectives by using HIV surveillance data : United States and 6 dependent areas, 2015
Shacara Johnson Lyons,Anna Satcher Johnson,Xiaohong Hu,Chenchen Yu,Chang Jin,Baohua Wu,Jianmin Li,Muhling Chong,Daneisha Hawkins,Shihua Wang,Joseph J. Logan,Norma Harris,Ya-lin Huang,Dawn K. Smith,Anne Harwood Peruski,Michael Friend +15 more
TL;DR: A diagnosis-based HIV continuum monitors key steps needed for a person living with diagnosed HIV infection to reach viral suppression, which leads to improved health outcomes and reduced risk for transmission to others.
Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States
TL;DR: The U.S. Department of Health and Human Services (DHHS) Working Group on Non Occupational Postexposure Prophylaxis (nPEP) made the following recommendations for the United States as mentioned in this paper.
Journal ArticleDOI
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
David Lanier,Neil Schram,Ellen C. Cooper,Kenneth A. Freedberg,Kenneth H. Mayer,Richard Blinkhorn,Jerrold J. Ellner,Fred Angulo,Ruth L. Berkelman,Robert F. Breiman,Ralph T. Bryan,James W. Buehler,Blake Caldwell,Kenneth G. Castro,James E. Childs,Susan Chu,Carol A. Ciesielski,D. Peter Drotman,Brian R. Edlin,Tedd V. Ellerbrock,Patricia L. Fleming,Larry Geiter,Rana A. Hajjeh,Debra L. Hanson,Scott D. Holmberg,James M. Hughes,Harold W. Jaffe,Jeffrey L. Jones,Dennis D. Juranek,Jonathan E. Kaplan,David W. Keller,William J. Martone,Michael M. Mc Neil,Bess Miller,Thomas R. Navin,Verla S. Neslund,Stephen M. Ostroff,Philip E. Pellett,Robert W. Pinner,Susan E. Reef,William C. Reeves,Russell L. Regnery,Frank O. Richards,Martha F. Rogers,Lawrence B. Schonberger,R. J. Simonds,Patricia M. Simone,Dawn K. Smith,Steven L. Solomon,Richard A. Spiegel,John A. Stewart,David L. Swerdlow,Suzanne D. Vernon,John W. Ward,Joyce J. Neal,Walter F. Schlech,Catherine M. Wilfert,Robert Horsburgh,John Mc Gowan,David Rimland,Mark Goldberger,Carol Braun Trapnell,David Barr,Gabriel Torres,Harrison C. Stetler,Peter A. Gross,Wafaa El-Sadr,Deborah J. Cotton,Wayne L. Greaves,John Bartlett,Richard E. Chaisson,Judith Feinberg,Thomas C. Quinn,Joseph Horman,Kristine Mac Donald,Mary E. Wilson,Rhoda S. Sperling,Alberto Avandano,A. Cornelius Baker,Anthony R. Kalica,Joseph A. Kovacs,Henry Masur,Michael A. Polis,Steven M. Schnittman,Charles Nelson,John P. Phair,Constance A. Benson,Bob Wood,Walter T. Hughes,Benjamin J. Luft,Newton E. Hyslop,Richard J. Whitley,Neil M. Ampel,W. Lawrence Drew,Jane E. Koehler,Constance B. Wofsy,James D. Neaton,Fred R. Sattler,Sharon A. Baker,Lawrence Corey,King K. Holmes,William G. Powderly +101 more
Journal ArticleDOI
Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force.
TL;DR: This investigation of patients with idiopathic CD4+ T-lymphocytopenia and unexplained opportunistic infections indicates that the disorder is rare and represents various clinical and immunologic states.